{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:09:25Z","timestamp":1792091365715,"version":"4.4.0"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,6,1]]},"DOI":"10.1038\/ajh.2012.26","type":"journal-article","created":{"date-parts":[[2012,3,15]],"date-time":"2012-03-15T13:22:22Z","timestamp":1331817742000},"page":"704-710","source":"Crossref","is-referenced-by-count":16,"title":["Amlodipine enhances amelioration of vascular insulin resistance, oxidative stress, and metabolic disorders by candesartan in metabolic syndrome rats"],"prefix":"10.1093","volume":"25","author":[{"given":"Daisuke","family":"Sueta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taishi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Fei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichiro","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobutaka","family":"Koibuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichiro","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Toyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisao","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shokei","family":"Kim-Mitsuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"key\n\t\t\t\t20170523184123_rf1","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.2337\/diacare.26.11.3160","article-title":"Follow-up report on the diagnosis of diabetes mellitus","volume":"26","author":"Expert Committee on the Diagnosis and Classification of Diabetes Mellitus","year":"2003","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t20170523184123_rf2","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1161\/01.HYP.33.5.1130","article-title":"Diabetes and cardiovascular events in hypertensive patients","volume":"33","year":"1999","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20170523184123_rf3","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1161\/01.HYP.0000125726.92964.ab","article-title":"Adverse prognostic significance of new diabetes in treated hypertensive subjects","volume":"43","year":"2004","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20170523184123_rf4","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jacc.2005.05.051","article-title":"Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials","volume":"46","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170523184123_rf5","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","article-title":"Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"LIFE Study Group","year":"2002","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170523184123_rf6","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/S0140-6736(04)16451-9","article-title":"Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial","volume":"363","author":"VALUE trial group","year":"2004","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170523184123_rf7","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1161\/HYPERTENSIONAHA.107.098475","article-title":"Effects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks: candesartan antihypertensive survival evaluation in Japan trial","volume":"51","author":"Candesartan Antihypertensive Survival Evaluation in Japan Trial Group","year":"2008","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20170523184123_rf8","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1097\/HJH.0b013e3282f0580f","article-title":"2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension","volume":"25","author":"ESH-ESC Task Force on the Management of Arterial Hypertension","year":"2007","journal-title":"J Hypertens"},{"key":"key\n\t\t\t\t20170523184123_rf9","first-page":"3","article-title":"The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)","volume":"32","author":"Japanese Society of Hypertension Committee","year":"2009","journal-title":"Hypertens Res"},{"key":"key\n\t\t\t\t20170523184123_rf10","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1056\/NEJMoa0806182","article-title":"Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients","volume":"359","author":"ACCOMPLISH Trial Investigators","year":"2008","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170523184123_rf11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jacc.2010.02.046","article-title":"Cardiovascular events during differing hypertension therapies in patients with diabetes","volume":"56","author":"ACCOMPLISH Investigators","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170523184123_rf12","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1161\/01.ATV.0000254855.24394.f9","article-title":"Pravastatin enhances beneficial effects of olmesartan on vascular injury of salt-sensitive hypertensive rats, via pleiotropic effects","volume":"27","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key\n\t\t\t\t20170523184123_rf13","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1161\/ATVBAHA.107.153692","article-title":"Novel mechanism and role of angiotensin II induced vascular endothelial injury in hypertensive diastolic heart failure","volume":"27","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key\n\t\t\t\t20170523184123_rf14","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s00125-009-1575-5","article-title":"Aliskiren prevents cardiovascular complications and pancreatic injury in a mouse model of obesity and type 2 diabetes","volume":"53","year":"2010","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t20170523184123_rf15","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1681\/ASN.2006080944","article-title":"Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: possible contribution of fat-derived factors","volume":"17","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170523184123_rf16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000323535","article-title":"Comparison of combination therapy of olmesartan plus azelnidipine or hydrochlorothiazide on renal and vascular damage in SHR\/NDmcr-cp rats","volume":"34","year":"2011","journal-title":"Kidney Blood Press Res"},{"key":"key\n\t\t\t\t20170523184123_rf17","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1097\/01.ASN.0000062961.76776.C1","article-title":"Anti-hypertensive agents inhibit in vivo the formation of advanced glycation end products and improve renal damage in a type 2 diabetic nephropathy rat model","volume":"14","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170523184123_rf18","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1161\/01.ATV.0000097770.66965.2A","article-title":"Novel vascular biology of third-generation L-type calcium channel antagonists: ancillary actions of amlodipine","volume":"23","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key\n\t\t\t\t20170523184123_rf19","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1161\/01.CIR.97.6.576","article-title":"Amlodipine releases nitric oxide from canine coronary microvessels: an unexpected mechanism of action of a calcium channel-blocking agent","volume":"97","year":"1998","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170523184123_rf20","doi-asserted-by":"crossref","first-page":"27L","DOI":"10.1016\/S0002-9149(99)00362-8","article-title":"Amlodipine promotes kinin-mediated nitric oxide production in coronary microvessels of failing human hearts","volume":"84","year":"1999","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20170523184123_rf21","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.2337\/db07-1111","article-title":"Effect of endothelium-specific insulin resistance on endothelial function in vivo","volume":"57","year":"2008","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t20170523184123_rf22","doi-asserted-by":"crossref","first-page":"E1311","DOI":"10.1152\/ajpendo.00299.2007","article-title":"Accelerated endothelial dysfunction in mild prediabetic insulin resistance: the early role of reactive oxygen species","volume":"293","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"key\n\t\t\t\t20170523184123_rf23","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.lfs.2005.06.029","article-title":"Disturbances in nitric oxide\/cyclic guanosine monophosphate system in SHR\/NDmcr-cp rats, a model of metabolic syndrome","volume":"78","year":"2006","journal-title":"Life Sci"},{"key":"key\n\t\t\t\t20170523184123_rf24","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/01.CIR.0000021924.02006.BA","article-title":"Nifedipine indirectly upregulates superoxide dismutase expression in endothelial cells via vascular smooth muscle cell-dependent pathways","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170523184123_rf25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1262-3636(07)70084-8","article-title":"Adipose tissue and adipokines: for better or worse","volume":"30","year":"2004","journal-title":"Diabetes Metab"},{"key":"key\n\t\t\t\t20170523184123_rf26","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1172\/JCI118709","article-title":"Obesity\/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance","volume":"97","year":"1996","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20170523184123_rf27","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/ajh.2010.239","article-title":"Globular and full-length adiponectin induce NO-dependent vasodilation in resistance arteries of Zucker lean but not Zucker diabetic fatty rats","volume":"24","year":"2011","journal-title":"Am J Hypertens"},{"key":"key\n\t\t\t\t20170523184123_rf28","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/ajh.2010.214","article-title":"Effect of red wine on adipocytokine expression and vascular alterations in fructose-fed rats","volume":"24","year":"2011","journal-title":"Am J Hypertens"},{"key":"key\n\t\t\t\t20170523184123_rf29","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/ajh.2010.198","article-title":"Nifedipine, a calcium-channel blocker, attenuated glucose intolerance and white adipose tissue dysfunction in type 2 diabetic KK-A(y) mice","volume":"24","year":"2011","journal-title":"Am J Hypertens"},{"key":"key\n\t\t\t\t20170523184123_rf30","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1161\/HYPERTENSIONAHA.107.103580","article-title":"A number of marketed dihydropyridine calcium channel blockers have mineralocorticoid receptor antagonist activity","volume":"51","year":"2008","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20170523184123_rf31","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ajh.2011.34","article-title":"Telmisartan provides better renal protection than valsartan in a rat model of metabolic syndrome","volume":"24","year":"2011","journal-title":"Am J Hypertens"}],"container-title":["American Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajh\/article-pdf\/25\/6\/704\/17460226\/25_6_704.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,25]],"date-time":"2017-08-25T04:37:09Z","timestamp":1503635829000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajh\/article-lookup\/doi\/10.1038\/ajh.2012.26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,1]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6,1]]}},"URL":"https:\/\/doi.org\/10.1038\/ajh.2012.26","relation":{},"ISSN":["0895-7061","1941-7225"],"issn-type":[{"value":"0895-7061","type":"print"},{"value":"1941-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,1]]}}}